NCT06511908: Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
- State
- Under way
- Phase
- Phase 2
- People
- 50 planned
- Started
- 6 Nov 2024
- Primary completion
- 1 Jul 2027
- Arms
- 1, 2
- Results
- None posted
- 22 Jul 2024: Trial registered
- 6 Nov 2024: Trial started